Document Detail

Absorption and excretion of undegradable peptides: role of lipid solubility and net charge.
MedLine Citation:
PMID:  8996209     Owner:  NLM     Status:  MEDLINE    
Absorption and excretion of undegradable peptides were investigated with use of octapeptides synthesized from D-amino acids. D-Tyrosine was included in each peptide to permit labeling with 125I, D-glutamic acid or D-lysine were included to vary net electric charge and D-serine or D-leucine were included to vary lipid solubility. Peptides were administered parenterally or orally to normal rats drinking 5% glucose or maltose. Forty-five percent of a lipid-insoluble, negatively charged octapeptide added to the drinking fluid in milligram quantities was absorbed from the intestine and excreted intact in urine; 90% of this peptide was recovered in urine after parenteral injection. In contrast, lipophilic D-octapeptides were largely excreted in feces, even after subcutaneous injection; the amounts excreted in feces were correlated with oil/aqueous partition coefficients. Evidence is presented that lipophilic peptides entering liver cells combine with bile salts to form hydrophilic complexes that are secreted rapidly at high concentration in bile. At physiological concentrations of bile salts (5-40 mM) and nanomolar concentrations of peptide the binding is so complete that these undegradable peptides are rapidly cleared from liver to duodenal fluid in association with the bile salts. After reaching the ileum the bile salts are reabsorbed to blood, leaving the original lipophilic peptides to be excreted in the feces from which they can be extracted, purified and identified by high-pressure liquid chromatography. These mechanisms are discussed in relation to a) the paracellular absorption of peptides and other solutes by solvent drag and b) the delivery and fate of biologically active peptides.
J R Pappenheimer; M L Karnovsky; J E Maggio
Related Documents :
9421409 - Nutrient and peptide regulation of somatostatin-28 secretion from intestinal cultures.
3366649 - Peptide immunoreactivity in developing entero-endocrine cells in endodermal grafts.
24981969 - A structural perspective of compensatory evolution.
8605009 - Uroguanylin: cloning of preprouroguanylin cdna, mrna expression in the intestine and he...
25401109 - Hla-e: a novel player for histocompatibility.
9123979 - Gut regulatory peptides in young cattle and sheep.
19348869 - Structure and synthesis of polyisoprenoids used in n-glycosylation across the three dom...
21126069 - The red clover necrotic mosaic virus capsid as a multifunctional cell targeting plant v...
18309279 - Selection and target-site mapping of peptides inhibiting hcv ns5b polymerase using phag...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of pharmacology and experimental therapeutics     Volume:  280     ISSN:  0022-3565     ISO Abbreviation:  J. Pharmacol. Exp. Ther.     Publication Date:  1997 Jan 
Date Detail:
Created Date:  1997-02-10     Completed Date:  1997-02-10     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0376362     Medline TA:  J Pharmacol Exp Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  292-300     Citation Subset:  IM    
Department of Biology, Harvard University, Bedford, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bile / metabolism
Bile Acids and Salts / metabolism
Ileum / metabolism
Intestinal Absorption*
Oligopeptides / metabolism*
Grant Support
Reg. No./Substance:
0/Bile Acids and Salts; 0/Oligopeptides

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Role of corticosterone in the enhancement of the antibody response after acute cocaine administratio...
Next Document:  Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation...